IVOR ROYSTON
CIK 1026765 · CEO & President · last filed 2024-11-27
IVOR ROYSTON is a CEO & President who has filed 51 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for VIRX, was dated Nov 27, 2024. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $11.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.42M
4
51
$1.76M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | 858,340 | $0.01 | $8.4K | -$208.4K | 19 | 2024-11-27 |
| BIOCEPT INC (BIOC) Delisted | Director | 34,152 | $0.43 | $14.9K | $64.6K | 14 | 2022-09-08 |
| SNDX | Director | 625,545 | $18.25 | $11.42M | $1.80M | 3 | 2017-03-22 |
| MMRGlobal, Inc. (FVRL) Delisted | Director | 123,155 | — | — | $105.2K | 3 | 2007-11-06 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-27 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2024-09-12 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2024-06-24 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2024-02-27 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2023-11-28 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2023-08-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2023-06-09 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |
| 2023-02-28 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +25,219 | $0 | EDGAR |